Optimizing Guideline-Recommended Antibiotic Doses for Pediatric Infective Endocarditis
Kristen R Nichols1, Emily N Israel2, Christopher A Thomas3
1Butler University, Indianapolis, IN, USA Indiana University Health, Indianapolis, IN, USA Indiana University School of Medicine, Indianapolis, IN, USA knichols@butler.edu.
Insights
Current guidelines for pediatric infective endocarditis antibiotic dosing lack pharmacokinetic optimization. This perspective highlights evidence-based improvements for vancomycin, aminoglycoside, and β-lactam regimens in children.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacology
- Cardiology
Background:
- The American Heart Association released updated guidelines for childhood infective endocarditis management.
- Current recommendations for vancomycin, aminoglycoside, and β-lactam dosing rely heavily on expert opinion.
- These guidelines do not fully incorporate pharmacokinetic/pharmacodynamic (PK/PD) principles for pediatric dosing optimization.
Purpose of the Study:
- To critically evaluate the antibiotic dosing and monitoring recommendations in the recent American Heart Association scientific statement on pediatric infective endocarditis.
- To highlight the need for evidence-based dose optimization using PK/PD principles in pediatric patients.
- To advocate for the inclusion of pediatric clinical pharmacists in future guideline development.
Main Methods:
- Perspective piece analyzing existing literature and guideline recommendations.
- Review of evidence supporting antibiotic dose optimization in pediatric populations.
- Discussion of potential improvements to current dosing strategies.
Main Results:
- Guideline-recommended doses may not be optimal for pediatric patients due to PK/PD variability.
- Existing evidence supports tailored dosing for vancomycin, aminoglycosides, and β-lactams to improve efficacy and safety.
- Hesitancy to deviate from established doses may limit effective treatment.
Conclusions:
- Future updates to infective endocarditis guidelines should integrate PK/PD data for pediatric antibiotic dosing.
- Involving pediatric clinical pharmacists with antibiotic expertise is crucial for refining these recommendations.
- Optimized antibiotic dosing is essential for improving clinical outcomes in pediatric infective endocarditis.
Abstract:
The American Heart Association recently published an updated scientific statement on the management of infective endocarditis in childhood. The recommendations included for vancomycin, aminoglycoside, and β-lactam dosing and monitoring are based primarily on expert opinion and do not consider available evidence for dose optimization based on pharmacokinetic and pharmacodynamic principles in pediatric patients. This is concerning because even when clinically necessary, some practitioners may be hesitant to deviate from guideline-recommended doses. In this perspective, we highlight potential areas for improvement in the statement-recommended doses and summarize evidence supporting antibiotic dosing optimization. The addition of a pediatric clinical pharmacist with expertise in antibiotic dosing to the panel would be beneficial for future updates.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Endocarditis III: Medical Management
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Endocarditis IV: Nursing Management
Dosage Interval and Administration Route: Determination Methods


